Skip to content
HowShorted

OPKO Health, Inc. short interest in 2023

In 2023, OPKO Health, Inc.'s disclosed short interest ran from 4.85% of shares outstanding on 13 Jan 2023 to 3.49% on 29 Dec 2023, a change of -1.36 percentage points. The year's high was 5.35% on 31 May 2023 and its low 3.49% on 29 Dec 2023, averaging 4.56% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.18 days on 28 Apr 2023. Full history: OPKO Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for OPKO Health, Inc. in 2023

2023 in figures

Start of year
4.85% (13 Jan 2023)
End of year
3.49% (29 Dec 2023)
Change
-1.36 pp
High
5.35% (31 May 2023)
Low
3.49% (29 Dec 2023)
Average
4.56%
Highest days to cover
21.18 (28 Apr 2023)
SEC filings marked
8

Every report in 2023

OPKO Health, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20234.85%15.79
31 Jan 20234.69%13.35
15 Feb 20234.52%15.41
28 Feb 20234.87%13.33results (8-K), 10-K filed
15 Mar 20235.07%6.33
31 Mar 20235.22%14.93
14 Apr 20235.05%15.17
28 Apr 20235.19%21.18
15 May 20235.29%15.6710-Q filed, results (8-K)
31 May 20235.35%17.01
15 Jun 20235.16%13.45
30 Jun 20235.04%4.32
14 Jul 20234.73%12.10
31 Jul 20234.38%11.93
15 Aug 20234.35%10.4110-Q filed, results (8-K)
31 Aug 20234.45%12.27
15 Sep 20234.37%18.70
29 Sep 20234.20%14.91
13 Oct 20234.13%16.94
31 Oct 20233.87%15.73
15 Nov 20233.77%13.7210-Q filed, results (8-K)
30 Nov 20233.73%15.69
15 Dec 20233.65%13.30
29 Dec 20233.49%12.84

See also: OPKO Health, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.